Conference for Alzheimer's Disease researchers
2025 Charleston Conference on Alzheimer's Disease Reunion
The 2025 Charleston Conference on Alzheimer's Disease is a friendly gathering for scientists to share ideas and work together on new ways to understand and treat Alzheimer's, happening in beautiful San Juan, Puerto Rico, from April 6 to April 10, 2025.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11066165 on NIH RePORTER |
What this research studies
The 2025 Charleston Conference on Alzheimer's Disease Reunion aims to gather established and emerging scientists in the field of Alzheimer's disease research for collaboration and discussion. This event will take place from April 6 to April 10, 2025, in San Juan, Puerto Rico, and will focus on fostering innovative research ideas and networking opportunities. Participants will engage in discussions that could lead to new research directions and collaborative projects, ultimately enhancing the understanding and treatment of Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals involved in Alzheimer's disease research, including early-career scientists and established researchers.
Not a fit: Patients who are not involved in Alzheimer's research or do not have a professional interest in the field may not receive direct benefits from this conference.
Why it matters
Potential benefit: If successful, this conference could lead to breakthroughs in Alzheimer's research that improve patient care and treatment options.
How similar studies have performed: Previous conferences have successfully fostered collaborations and led to significant advancements in Alzheimer's research.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Lin, Ai-Ling — University of Missouri-Columbia
- Study coordinator: Lin, Ai-Ling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.